Hemogenyx Pharmaceuticals loss narrows amid reduced expenses
Hemogenyx Pharmaceuticals PLC on Friday said its pretax loss narrowed in the first half of 2024, following a reduction in expenses.
The London-based biopharmaceutical company...
Fri, 27/09/2024 - 18:25